Heart Test Laboratories Inc. Common Stock (HSCS) — Cash Flow-to-Debt Ratio
Heart Test Laboratories Inc. Common Stock (HSCS) has a Cash Flow-to-Debt Ratio of -1287.06x as of October 2025, meaning its operating cash flow of $-2.33 Billion could theoretically repay -1287% of its total liabilities ($1.81 Million) in one year. Explore HSCS cash flow conversion to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Heart Test Laboratories Inc. Common Stock Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Heart Test Laboratories Inc. Common Stock across 6 annual periods. Also explore HSCS total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Heart Test Laboratories Inc. Common Stock (2020–2025)
Year-by-year debt coverage analysis for Heart Test Laboratories Inc. Common Stock. For market capitalisation and broader financial context, see Heart Test Laboratories Inc. Common Stoc (HSCS) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.85x | $-7.41 Million | $4.02 Million | ▲ +33.6% |
| 2024 | -2.78x | $-6.07 Million | $2.19 Million | ▼ -47.0% |
| 2023 | -1.89x | $-5.77 Million | $3.06 Million | ▼ -322.2% |
| 2022 | -0.45x | $-3.64 Million | $8.15 Million | ▲ +30.0% |
| 2021 | -0.64x | $-2.45 Million | $3.84 Million | ▲ +72.7% |
| 2020 | -2.34x | $-3.84 Million | $1.64 Million | — |